EXELIXIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.99 USD | -1.32% |
|
-5.24% | -12.51% |
| 05-14 | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
| 05-10 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
b7.YZ0yzcbPol_heFaTQuo13hGClutms0oXHCh5kygrjaA.OM1WlKn6lWa5IT3xIZBz51_o2oYFgz96aBwf8Ut0yPMg2QWjpfmQKIgdBw~108bfe8f1ebf8e36677173fda64fea16